Navigation Links
New drugs for resistant forms of TB

An international meeting on breathing disorders in Paris discussed the ongoing research on development of new drugs against tuberculosis. //There is a need to revamp the more than a century old test that takes a long time for detection and drugs to which the strains of TB have become resistant.

According to Nils Billo, one of the organisers of the 37th world congress of the Union for breathing health and executive director of the Paris-based International Union Against Tuberculosis and Breathing Disorders (UNION), 2 new methods of development of new drugs against TB are being discussed.

"During the Paris conference, we will witness the presentation of the research work conducted by two teams. The response we get from these works is that which sustains the hope of getting new drugs against the disease in the next few years," Billo said.

The multi-drug resistant TB that is resistant to the antibiotics isoniazid and rifampin has been a major cause of concern to the health officials for more than a decade.

He said, "The new drugs, if developed, would take into account the resistance of tuberculosis to the already existing antibiotics, their prices would be affordable even in developing countries."

"The making of new drugs will arguably be a decisive element in the fight against TB but this fight could be won only if southern countries have significant human resources on the fight against tuberculosis," Billo said.

Tuberculosis is the world's deadliest curable infectious respiratory disease that spreads by coughing and sneezing. According to the World Health Organization, it claims 1.7 million lives every year.

Asthma and tobacco addiction will also be discussed in the conference attended by over 2,000 participants from 130 countries.
GYT
'"/>




Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
3. African HIV strains more resistant to anti HIV drugs
4. Right drugs drastically cut stroke risk
5. Relating heart protection and antihypertensive drugs
6. Enzyme may be target for obesity drugs
7. New HIV cases resist drugs
8. Relief to pregnant women using fertility drugs
9. AIDS drugs linked to heart attack risk
10. FDA debates status of decongestant drugs
11. Status of some prescription drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Dublin, CA (PRWEB) , ... June 27, 2016 ... ... Community College District , the only authorized OSHA Training Institute Education Center headquartered ... illness by protecting their workers from extreme heat at their worksites. Employers ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... NY (PRWEB) , ... June 27, 2016 , ... ... using cutting edge technology to revolutionize the emergency ambulance transport experience for the ... are aware of how Uber has disrupted the taxi industry through the use ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: